Press release content from Business Wire. The AP news staff was not involved in its creation.
AI Driven Application Innovator, EverestIMS Technologies signs distribution agreement with Australia-based AppDistri
March 2, 2021 GMT
BENGALURU, India & SINGAPORE & MELBOURNE, Australia (BUSINESS WIRE) Mar 1, 2021
EverestIMS Technologies, an award-winning global innovator in the AI based solutions for IT operations management, is happy to announce a partnership with Australia based AppDistri. EverestIMS solutions are used by some of the biggest global companies in the Enterprise market, MSPs’, Finance & Telecom industries. They count organizations like Federal Bank, PayTM, Reliance Group and Airtel as customers.
AppDistri will become the strategic distribution partner for EverestIMS’ Infraon Solution Suite across APAC and North America. The partnership key focus is to introduce EverestIMS’ AI based digital transformation solutions to enterprise customers in Australia, New Zealan
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Document Security Systems Strengthens Its Interest in Sharing Services Global Corporation .
Document Security Systems Inc.March 1, 2021 GMT
ROCHESTER, N.Y., March 01, 2021 (GLOBE NEWSWIRE) Document Security Systems, Inc. (NYSE American: DSS) (“DSS”) announced today in a joint press release that it has increased its investment in Sharing Services Global Corporation (OTCQB: SHRG) (“Sharing Services”), a publicly traded company dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products, and technologies in the direct selling industry, through a $30 million convertible promissory note.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Idorsia submits NDA for clazosentan to Japanese PMDA
Idorsia Pharmaceuticals LtdMarch 1, 2021 GMT
Allschwil, Switzerland – March 1, 2021
Idorsia Ltd (SIX: IDIA) today announced the submission of a New Drug Application (NDA) to the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for clazosentan, a fast-acting, selective endothelin A (ETA) receptor antagonist, for the prevention of cerebral vasospasm, vasospasm-related cerebral infarction and cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage (aSAH).
The application is supported by replicated results from the Japanese registration program which consisted of two double-blind, randomized, placebo-controlled studies assessing the efficacy and safety of clazosentan in reducing vasospasm-related morbidity and all-cause mortality events in adult Japanese patients following aSAH. Patients were randomized to receiv
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
TILT Holdings Inc. Receives Approval for Additional Cultivation Expansion at its Massachusetts .
TILT Holdings Inc.March 2, 2021 GMT
Combination of Phase One and Phase Two Expansion More
Than Doubles Company’s Cultivation Capacity in Commonwealth
Company’s Expanded Facility Supports B2B Brand Strategy While
Addressing Massachusetts’ Growing Marketplace Demands
PHOENIX, March 02, 2021 (GLOBE NEWSWIRE) TILT Holdings Inc. (“TILT” or the “Company”) ( CSE: TILT ) ( OTCQX: TLLTF ), a provider of business solutions to the global cannabis industry that includes inhalation technologies, cultivation, manufacturing, processing, brand development, distribution and retail, announced it received regulatory approval from the Massachusetts Cannabis Control Commission (“CCC”) to commence operation of eight additional grow rooms at its subsidiary, Commonwealth Alternative Care